Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 7OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Basal Cell Nevus Syndrome 1

Interventions

Cyclophosphamide 2068Radiotherapy 1990Cisplatin 1857Carboplatin 1560Gemcitabine 1455Paclitaxel 1322Bevacizumab 1321pembrolizumab 1240Docetaxel 1227Oxaliplatin 1184Capecitabine 1179Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 973Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 641Lenalidomide 619Biopsy 595Specimen Handling 570

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × BMS-833923 × Clear all
NCT02100371 2017-07-11

Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome

University Health Network, Toronto

Phase NA Completed
2 enrolled
Dermatologic

Basal Cell Nevus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡